We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New RNAi Treatment Targets Eye Inflammation

News   Feb 15, 2017 | Original story from Hokkaido University

 
New RNAi Treatment Targets Eye Inflammation

The newly developed RNAi agent suppressed chronic inflammation in the retinas of diabetic mice. The number of leukocytes (arrows) in the inflamed vasculature was significantly reduced in the RNAi-treated retina (right) comparing to the control experiment (left). Credit: Hokkaido University

 
 
Advertisement
 

RELATED ARTICLES

New Method Optimizes Production of Insulin-Producing Cells

News

Scientists are developing a promising approach for treating type 1 diabetes using stem cells to create insulin-producing cells that could replace nonfunctional pancreatic cells.

READ MORE

Drug Sensitivity of Liver Cancer Cells

News

A study has shown that hepatocellular cancer cells cultured in more native conditions can have a different phenotype and varied drug sensitivity to those cultured in standard conditions.

READ MORE

Molecular Mechanism of Immune Cell Migration Revealed

News

Researchers have discovered the novel molecular mechanism behind immune cell migration.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE